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The usage of gadolinium-enhanced cardiac magnetic 
resonance (CMR) in the differentiation of heart failure 
related to dilated cardiomyopathy and coronary artery disease 
has been demonstrated in previously published studies. It 
currently remains one of the basic methods for assessing 
myocardial ischemia, which has been reflected in many 
international guidelines, including those of the European 
Society of Cardiology (1-3). Also, T2 mapping for myocardial 
edema, cine CMR for regional wall motion abnormalities, 
rest first pass and adenosine stress perfusion are well 
sanctioned methods of myocardial ischemia assessment, also 
used in patients with acute coronary syndromes (4-6). 
Nowadays, procedural myocardial infarction (PMI) 
accompanying percutaneous coronary interventions (PCIs) 
are mostly determined by the 3rd Universal Definition of 
Myocardial Infarction (UDMI) (7). However, an increasing 
trend to modify this definition has appeared, and among 
others, the most popular new definition seems to be the one 
established by the Society for Cardiovascular Angiography 
and Interventions (SCAI) (8). In several studies, it has been 
noted that poorer prognosis after PMI in patients treated 
with PCI of native coronary arteries, expressed as increased 
mortality, is related to the amount of damaged myocardium 
which can be assessed by CMR (9,10). Troponin C (cTn) 
is considered a more sensitive marker of myocardial injury 
than creatinine kinase-myocardial band (CK-MB) (11). 
During a 1-year follow-up period, it has been demonstrated 
that only relatively large increases in CK-MB (more than 
10 times over the upper, normal limit) significantly correlate 
with increased mortality in patients undergoing non-
emergent PCI (12). However, some studies did not reveal 
a similar relationship with poorer clinical outcomes during 
follow-up after PCIs even for high levels of PMI markers, 
including the level of CK-MB (13). In their analysis, 
Lim et al. showed that according to the 3rd UDMI, cTn 
is oversensitive in the diagnosis of PMI in comparison to 
CK-MB, and it is identified in a large number of patients 
without evidence of PMI confirmed by CMR indicating 
that CK-MB is a better indicator of MI type 4a (14). 
Moreover, some publications indicate that the association of 
post-procedural level of markers of myocardial injury with 
long-term clinical outcomes expressed as major adverse 
clinical events mostly depends on greater atherosclerotic 
burden (15). This thesis is especially applicable to patients 
treated with rotablation, where multi-vessel disease of 
coronary arteries prevails in the angiographic presentation 
of coronary artery disease. Considering the above reports, 
a new PMI definition was proposed by the SCAI based on 
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the level of myocardial necrosis indicators, which requires 
higher levels of those biomarkers for the diagnosis of 
PMI when compared to the 3rd UDMI (8). In a previously 
published study, we demonstrated that rotablation is 
associated with higher rates of intraprocedural myocardial 
infarction compared to the group of other patients treated 
with PCI without rotablation. However, this did not show 
statistical significance (16). Also, Stone et al. demonstrated 
that based on serum biomarkers of myocardial injury 
and cut points, the elective athero-rotablation with stent 
placement is associated with a higher rate of PMI compared 
to the elective PCIs without rotablation (17). The authors 
of that study justified this observation with the greater 
extent of atherosclerotic burden and calcifications, and 
indicated that this increased level of myocardial injury 
markers is rather procedure-related than a sign of real and 
significant clinical complications (18). 
The novelty of the study published by McEntegart 
et al. is presented via the use of CMR in assessing the PMI 
in patients treated with rotablation (19). Although no 
control group was included in the study, it still delivers new 
insight. As suspected, the PMI rate is higher in this study 
when assessed by the 3rd UDMI (10% of patients) compared 
to the SCID definition (4% of patients). Unexpectedly, 
it increased after applying the CMR method in addition 
to the 3rd UDMI to 24%. It still remained elevated after 
seven days when assessed using CMR with late gadolinium 
enhancement (16% of participants) and after 6 months of 
follow-up (14% of all participants) when compared to PMIs 
diagnosed by each of the serum biomarkers separately. This 
observation causes some shame, due to the fact that it was 
expected that CMR would decrease the number of patients 
with confirmed PMI by the 3rd UDMI, especially, those 
where cTn was used as a cut point. Specific circumstances 
related to the rotablation procedure include the fact that 
debris released during rotablation is denser than in regular 
plastics, where debris is much softer and the occasional 
occlusion of small and peripheral vessels seems to be 
greater. On the other hand, the rate of perforations and 
dissections is also relatively high in the group of patients 
treated with rotablation compared to those treated without 
it (16). Based on this, the explanation of the presented 
results seems to be extremely difficult. Especially taking 
the results of previously published studies into account, 
in which the diagnosis of PMI using CMR was better 
correlated with CK-MB than troponin (20). Furthermore, 
Kim et al. confirmed that myocardial infarction diagnosed 
by CK-MB correlates with the CMR diagnosis in terms of 
infarct size (21). A similar relationship was observed in a 
recently published study performed in a group of patients 
undergoing off-pump coronary artery bypass operations, 
in which increased post-operative level of troponin was 
less often associated with the area of myocardial injury 
confirmed by CMR (22). Another fact deserving attention 
is the small group of patients which causes some paucity, in 
particular, there is no data regarding which of the methods 
of PMI diagnosis correlate best with follow-up major 
adverse cardiac events, including mortality (19). One of the 
reasons is the relatively short period of observation. This 
could be a crucial finding in this group of patients. 
In summary, the results are interesting and promising, 
however, they require further multi-centre studies enclosing 
greater numbers of participants, preferably with a control group.
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